Our article on the photocatalytic degradation of carbamazepine and cyclophosphamide has been published

This study presents a novel magnetic photocatalyst designed to remove persistent pharmaceutical pollutants from water. The research focuses on the degradation of carbamazepine, an antiepileptic drug, and cyclophosphamide, a cytostatic compound frequently detected in surface waters.

By combining photocatalysis with a persulfate-based advanced oxidation process under simulated sunlight, the developed material showed high efficiency in breaking down both pharmaceuticals. The enhanced performance results from the unique structure of the catalyst.

Complete degradation of carbamazepine was achieved within 20 minutes, while up to 90% of cyclophosphamide was removed within 90 minutes.

Thanks to its magnetic properties, the photocatalyst can be easily separated from water after treatment, making this approach a promising and practical solution for advanced water purification technologies.

Programme Manual Online

Choose